Position in PFE
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$1,520,242
-$214,175 QoQ
Shares Held
63,133
+2.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.69%
of 13F equity value
Holder Rank
#1,089
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Wealth Management Associates, Inc. holds $14,108,701 across 10 Drug Manufacturers - General names. PFE ranks #5 (10.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
13,266 | $3,369,166 | |
| 2 | LLY |
ELI LILLY & Co
|
2,744 | $3,291,236 | |
| 3 | MRK |
Merck & Co., Inc.
|
15,581 | $2,002,158 | |
| 4 | ABBV |
AbbVie Inc.
|
6,759 | $1,700,834 | |
| 5 | PFE |
Pfizer Inc
This page
|
63,133 | $1,520,242 | |
| 6 | AMGN |
Amgen Inc
|
3,099 | $1,122,209 | |
| 7 | AZN |
Astrazeneca PLC
|
1,780 | $337,523 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
2,535 | $320,271 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,520,242 | 63,133 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $1,734,417 | 61,767 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,519,348 | 61,018 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $1,348,070 | 52,907 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $1,353,391 | 55,833 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $1,386,604 | 54,720 | Shares | Sole | 2025-05-28 | |
| 2024-12-31 | $1,317,665 | 49,667 | Shares | Sole | 2025-05-28 | |
| 2024-09-30 | $1,403,011 | 48,480 | Shares | Sole | 2025-05-28 | |
| 2024-06-30 | $1,332,883 | 47,637 | Shares | Sole | 2025-05-28 | |
| 2024-03-31 | $1,321,926 | 47,637 | Shares | Sole | 2025-05-28 | |
| 2023-12-31 | $1,261,433 | 43,815 | Shares | Sole | 2025-05-28 | |
| 2023-09-30 | $1,360,865 | 41,027 | Shares | Sole | 2025-05-28 | |
| 2023-06-30 | $1,488,034 | 40,568 | Shares | Sole | 2025-05-28 | |
| 2023-03-31 | $1,676,757 | 41,097 | Shares | Sole | 2025-05-28 | |
| 2022-12-31 | $2,119,337 | 41,361 | Shares | Sole | 2025-05-28 | |
| 2022-09-30 | $1,917,300 | 43,814 | Shares | Sole | 2025-05-28 | |
| 2022-06-30 | $2,310,065 | 44,060 | Shares | Sole | 2025-05-28 | |
| 2022-03-31 | $2,460,369 | 47,525 | Shares | Sole | 2025-05-28 | |
| 2021-12-31 | $2,652,466 | 44,919 | Shares | Sole | 2025-05-28 | |
| 2021-09-30 | $1,784,312 | 41,486 | Shares | Sole | 2025-05-28 | |
| 2021-06-30 | $1,628,116 | 41,576 | Shares | Sole | 2025-05-28 | |
| 2021-03-31 | $1,516,116 | 41,847 | Shares | Sole | 2025-05-28 | |
| 2020-12-31 | $1,859,015 | 50,503 | Shares | Sole | 2025-05-28 | |
| 2020-09-30 | $1,653,003 | 45,041 | Shares | Sole | 2025-05-28 | |
| 2020-06-30 | $1,208,233 | 36,949 | Shares | Sole | 2025-05-28 | |
| 2020-03-31 | $1,150,329 | 35,243 | Shares | Sole | 2025-05-28 | |
| No filing history on record for this holder in this stock. | ||||||